Medication persistence rates and predictive factors for discontinuation of antifibrotic agents in patients with idiopathic pulmonary fibrosis: a real-world observational study

BACKGROUND: In patients with idiopathic pulmonary fibrosis (IPF), continuing treatment with antifibrotic agents is crucial to decrease the reduction of forced vital capacity and mortality rate. However, predictive factors for the discontinuation of antifibrotic agents are unknown. This study aims to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Respir Dis
Autores principales: Oishi, Keiji, Hirano, Tsunahiko, Murata, Yoriyuki, Hamada, Kazuki, Uehara, Sho, Suetake, Ryo, Yamaji, Yoshikazu, Asami-Noyama, Maki, Edakuni, Nobutaka, Ohata, Syuichiro, Utsunomiya, Toshiaki, Sakamoto, Kenji, Onoda, Hideko, Matsumoto, Tsuneo, Matsunaga, Kazuto, Yano, Masafumi
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6719482/
https://ncbi.nlm.nih.gov/pubmed/31476961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619872890
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares